Advertisement

Topics

Search Results for "April 2013 Update On Transvaginal Mesh Lawsuits"

06:11 EDT 29th July 2016 | BioPortfolio

Matching Channels

Proliferation inducing ligand APRIL

Treatment of inflammatory and autoimmune diseases such as systemic lupus erythematosus (SLE), rheumatoid arthritis and multiple sclerosis.

Abiraterone Acetate - Zytiga

On April 28, 2011, the US Food and Drug Administration (FDA) approved Zytiga (abiraterone acetate), for use in combination with prednisone for the second-line treatment of castration-resistant prost...

iBioLaunch

The iBioLaunch™ platform is a  proprietary gene expression technology that causes non-transgenic plants to rapidly produce high levels of target proteins.  The plants are easily and ...

Veregen

Veregen® is an ointment used to treat external genital warts. In the USA, Germany, Austria, Spain, Switzerland and Serbia, Veregen® is already marketed by our partners. Sales and marketing p...

Kinases Raf Inhibitors

The Ras-Raf-MEK-ERK (ERK) pathway is a logical therapeutic target because it represents a common downstream pathway for several key growth factor tyrosine kinase receptors which are often mutated or...

Matching News

J&J Agrees to Pay Over $120M to Settle Thousands of Mesh Lawsuits

Johnson & Johnson offered a large settlement to resolve its first big group of transvaginal mesh lawsuits, Bloomberg reported. The company agreed to settle as many as 3,000 cases for more than $12...

Transvaginal Mesh Settlement News: J&J's Ethicon Gets Hit with $13.5MM Jury Verdict

PHILADELPHIA, Feb. 29, 2016 /PRNewswire/ -- MT Services LLC, a Lawsuit Settlement News Reporting Company which operates lawsuitsettlementnews.com, announced today that in the latest transvag...

Breaking News from Legal-Bay: Johnson & Johnson Settles for $120MM in First Big Transvaginal Mesh Settlement

PHILADELPHIA, Feb. 3, 2016 /PRNewswire/ -- Legal-Bay LLC, The Lawsuit Settlement Funding Company, reported today that Johnson & Johnson has finally made its first serious attempt to start res...

Strengthening Surgical Mesh Safety

Two final orders from the FDA have targeted serious complications linked with surgical mesh used for transvaginal repair of pelvic organ prolapse.

Women Plan Rally As Jury Rules J&J Will Pay $13.5M for Mesh Verdict

A Philadelphia jury ruled in favor of a woman in the second transvaginal mesh trial against Johnson & Johnson’s Ethicon subsidiary since December. Now, women advocating against mesh plan to...

$13.5MM Jury Verdict Reached Against J&J's Ethicon

PHILADELPHIA, Feb. 12, 2016 /PRNewswire/ -- Legal-Bay LLC, The Lawsuit Settlement Funding Company, reported today that a Philadelphia jury returned a $13.5 million verdict against Johnson & Johnso...

Pelvic Mesh Lawsuit Funding Firm, Fair Rate Funding, Reports Missouri Verdict in Favor of Mesh Manufacturers

MANASQUAN, N.J., Feb. 4, 2016 /PRNewswire/ -- Fair Rate Funding, a leader in TV mesh lawsuit funding, reports another jury verdict in favor of mesh manufacturers in the widely publicized on going tran...

TV Mesh Lawsuit Funding Firm, Fair Rate Funding, Reports Another Million Dollar Verdict Against Johnson and Johnson

MANASQUAN, N.J., Feb. 19, 2016 /PRNewswire/ -- Fair Rate Funding, a transvaginal mesh lawsuit funding company, reports a verdict in favor of Teresa Taylor against Johnson and Johnson (J&J) in a pr...

Matching PubMed Articles

Transvaginal mesh in the media following the 2011 US food and drug administration public health notification update.

Prompted by patients' changing perceptions of transvaginal mesh, this study examines how mesh has been reported in the news following the 2011 US Food and Drug Administration (FDA) updated notificatio...

Graft and Mesh Use in Transvaginal Prolapse Repair: A Systematic Review.

To update clinical practice guidelines on graft and mesh use in transvaginal pelvic organ prolapse repair based on systematic review.

Surgeon Experience and Complications of Transvaginal Prolapse Mesh.

To measure the proportion of women with transvaginal prolapse mesh complications and their association with surgeon volume.

Age-stratified analysis of long-term outcomes of transvaginal mesh repair for treatment of pelvic organ prolapse.

To investigate long-term outcomes after transvaginal mesh repair among patients with pelvic organ prolapse in different age groups.

Risks of transvaginal mesh may be associated with an increased risk of urinary retention and reintervention.

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement